Alzamend Neuro (ALZN) Return on Equity [ROE] (2021 - 2026)
Alzamend Neuro (ALZN) reported Return on Equity [ROE] of -278.39% for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 144.30 percentage points from -134.09% a year earlier but up 319.82 percentage points from the prior quarter.
Powered by 
Analysis
Alzamend Neuro (ALZN) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2026 (ended Apr 30, 2026), Alzamend Neuro posted Return on Equity [ROE] of -373.18%, up 283.99 percentage points from FY2025.
- Return on Equity [ROE] has a five-year change of -13.75 percentage points (FY2021 to FY2026).
- By fiscal year, Return on Equity [ROE] came in at -657.17% in FY2025 (+3751.14 pp), -4408.31% in FY2024 (-4226.83 pp), -181.47% in FY2023 (-20.50 pp) and -160.97% in FY2022 (+198.46 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of -1048.13% in fiscal Q1 2024 and a high of -58.84% in fiscal Q2 2022.
- Year over year, Return on Equity [ROE] has now declined in each of the last three quarters, with an average year-over-year change of -94.55 percentage points over the last four quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was fiscal Q4 2022 (a gain of 1323.30 percentage points); the low point was fiscal Q1 2024 (a drop of 941.47 percentage points).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -598.22% (Q4 2026), -214.23% (Q3 2026) and -121.06% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Alzamend Neuro | 6.51 Mn | -8.95 Mn | - | -278.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -278.39% |
| Apr 30, 2026 | -598.22% |
| Jan 31, 2026 | -214.23% |
| Oct 31, 2025 | -121.06% |
| Jul 31, 2025 | -134.09% |
| Apr 30, 2025 | -121.73% |
| Jan 31, 2025 | -117.37% |
| Oct 31, 2024 | -460.51% |
| Jul 31, 2023 | -1,048.13% |
| Apr 30, 2023 | -334.15% |
| Jan 31, 2023 | -210.91% |
| Oct 31, 2022 | -126.13% |
| Jul 31, 2022 | -106.66% |
| Apr 30, 2022 | -97.70% |
| Jan 31, 2022 | -78.01% |
| Oct 31, 2021 | -58.84% |
| Jul 31, 2021 | -70.24% |
| Apr 30, 2021 | -1,421.01% |
API Access
Alzamend Neuro Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();